Designed Antimicrobial Peptides Towards Trauma-Associated Cutaneous Invasive Fungal Wound Infections
- Cutaneous invasive fungal wound infections after life-threatening dismounted complicated blast harm (DCBI) and pure disasters complicate scientific care. These wounds usually require aggressive repeated surgical debridement, may end up in amputations and hemipelvectomies and have a 38% mortality charge.
- Given the substantial morbidity related to cutaneous fungal wound infections, sufferers in danger want quick empiric remedy mandating the usage of quickly performing broad-spectrum antimicrobials, performing on each fungi and micro organism, which can be additionally efficient in opposition to biofilm and will be administered topically. Designed antimicrobial peptides (dAMPs) are engineered analogues of innate antimicrobial peptides which offer the primary line of protection in opposition to invading pathogens.
- The antifungal and antibacterial impact and mammalian cytotoxicity of seven modern dAMPs, created by iterative structural analog revisions and physicochemical and practical testing have been investigated. The dAMPs possess broad-spectrum antifungal exercise, along with being efficient in opposition to Gram-negative and Gram-positive micro organism, which is essential as many wounds are polymicrobial and require quick empiric remedy.
- Three of probably the most potent dAMPs-RP504, RP556 and RP557-possess restricted mammalian cytotoxicity following eight h incubation. If these encouraging broad-spectrum antimicrobial and fast performing outcomes are translated clinically, these novel dAMPs could grow to be a primary line empiric topical remedy for traumatic wound accidents.
.
antibodysource
CIDEB Antibody |
|||
| 1-CSB-PA001649 | Cusabio |
|
|
|
Description: A polyclonal antibody against CIDEB. Recognizes CIDEB from Human, Mouse. This antibody is Unconjugated. Tested in the following application: WB, IHC, IF, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.IF:1/200-1/1000.ELISA:1/40000 |
|||
CIDEB Antibody |
|||
| 1-CSB-PA552167 | Cusabio |
|
|
|
Description: A polyclonal antibody against CIDEB. Recognizes CIDEB from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:10000, IHC:1:50-1:200 |
|||
CIDEB Antibody |
|||
| CSB-PA596246- | Cusabio | each | 402 EUR |
|
Description: A polyclonal antibody against CIDEB. Recognizes CIDEB from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF;WB:1:500-1:3000, IHC:1:50-1:100, IF:1:100-1:500 |
|||
CIDEB Antibody |
|||
| CSB-PA596246-100ul | Cusabio | 100ul | 379.2 EUR |
|
Description: A polyclonal antibody against CIDEB. Recognizes CIDEB from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF;WB:1:500-1:3000, IHC:1:50-1:100, IF:1:100-1:500 |
|||
CIDEB Antibody |
|||
| 1-CSB-PA715372 | Cusabio |
|
|
|
Description: A polyclonal antibody against CIDEB. Recognizes CIDEB from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:10000, IHC:1:50-1:200 |
|||
CIDEB Antibody |
|||
| E034263 | EnoGene | 100μg/100μl | 255 EUR |
|
Description: Available in various conjugation types. |
|||
CIDEB Antibody |
|||
| DF3608 | Affbiotech | 200ul | 420 EUR |
CIDEB Antibody |
|||
| DF3608-100ul | Affinity Biosciences | 100ul | 168 EUR |
|
Description: WB,IHC,IF/ICC,ELISA(peptide) |
|||
CIDEB Antibody |
|||
| DF3608-200ul | Affinity Biosciences | 200ul | 210 EUR |
|
Description: WB,IHC,IF/ICC,ELISA(peptide) |
|||
CIDEB Antibody |
|||
| E11-13034C | EnoGene | 100μg | 225 EUR |
|
Description: Available in various conjugation types. |
|||
CIDEB Antibody |
|||
| E300582 | EnoGene | 100μg | 275 EUR |
|
Description: Available in various conjugation types. |
|||
CIDEB Antibody |
|||
| E38PA5391 | EnoGene | 100ul | 225 EUR |
|
Description: Available in various conjugation types. |
|||
CIDEB Antibody |
|||
| E19-3608 | EnoGene | 100μg/100μl | 225 EUR |
|
Description: Available in various conjugation types. |
|||
CIDEB Antibody |
|||
| GWB-MX419E | GenWay Biotech | 50ug | Ask for price |
CIDEB Antibody |
|||
| MBS7132800-01mL | MyBiosource | 0.1mL | 270 EUR |
CIDEB Antibody |
|||
| MBS7132800-5x01mL | MyBiosource | 5x0.1mL | 1200 EUR |
CIDEB Antibody |
|||
| MBS7049599-005mg | MyBiosource | 0.05mg | 190 EUR |
CIDEB Antibody |
|||
| MBS7049599-01mg | MyBiosource | 0.1mg | 270 EUR |
CIDEB Antibody |
|||
| MBS7049599-5x01mg | MyBiosource | 5x0.1mg | 1205 EUR |
CIDEB Antibody |
|||
| MBS7116135-005mg | MyBiosource | 0.05mg | 150 EUR |
CIDEB Antibody |
|||
| MBS7116135-01mg | MyBiosource | 0.1mg | 190 EUR |
CIDEB Antibody |
|||
| MBS7116135-5x01mg | MyBiosource | 5x0.1mg | 845 EUR |
CIDEB Antibody |
|||
| MBS7124437-005mL | MyBiosource | 0.05mL | 190 EUR |
CIDEB Antibody |
|||
| MBS7124437-01mL | MyBiosource | 0.1mL | 270 EUR |
CIDEB Antibody |
|||
| MBS7124437-5x01mL | MyBiosource | 5x0.1mL | 1205 EUR |
CIDEB Antibody |
|||
| MBS7124438-005mL | MyBiosource | 0.05mL | 190 EUR |
CIDEB Antibody |
|||
| MBS7124438-01mL | MyBiosource | 0.1mL | 270 EUR |
CIDEB Antibody |
|||
| MBS7124438-5x01mL | MyBiosource | 5x0.1mL | 1205 EUR |
CIDEB Antibody |
|||
| MBS8514338-01mg | MyBiosource | 0.1mg | 305 EUR |
CIDEB Antibody |
|||
| MBS8514338-01mLAF405L | MyBiosource | 0.1mL(AF405L) | 465 EUR |
CIDEB Antibody |
|||
| MBS8514338-01mLAF405S | MyBiosource | 0.1mL(AF405S) | 465 EUR |
CIDEB Antibody |
|||
| MBS8514338-01mLAF610 | MyBiosource | 0.1mL(AF610) | 465 EUR |
CIDEB Antibody |
|||
| MBS8514338-01mLAF635 | MyBiosource | 0.1mL(AF635) | 465 EUR |
CIDEB Antibody |
|||
| MBS9402263-005mL | MyBiosource | 0.05mL | 245 EUR |
CIDEB Antibody |
|||
| MBS9402263-01mL | MyBiosource | 0.1mL | 305 EUR |
CIDEB Antibody |
|||
| MBS9402263-5x01mL | MyBiosource | 5x0.1mL | 1230 EUR |
CIDEB Antibody |
|||
| MBS858145-01mg | MyBiosource | 0.1mg | 345 EUR |
CIDEB Antibody |
|||
| MBS858145-01mLAF405L | MyBiosource | 0.1mL(AF405L) | 565 EUR |
CIDEB Antibody |
|||
| MBS858145-01mLAF405S | MyBiosource | 0.1mL(AF405S) | 565 EUR |
CIDEB Antibody |
|||
| MBS858145-01mLAF610 | MyBiosource | 0.1mL(AF610) | 565 EUR |
CIDEB Antibody |
|||
| MBS858145-01mLAF635 | MyBiosource | 0.1mL(AF635) | 565 EUR |
CIDEB Antibody |
|||
| MBS858415-01mg | MyBiosource | 0.1mg | 305 EUR |
CIDEB Antibody |
|||
| MBS858415-01mLAF405L | MyBiosource | 0.1mL(AF405L) | 465 EUR |
CIDEB Antibody |
|||
| MBS858415-01mLAF405S | MyBiosource | 0.1mL(AF405S) | 465 EUR |
CIDEB Antibody |
|||
| MBS858415-01mLAF610 | MyBiosource | 0.1mL(AF610) | 465 EUR |
CIDEB Antibody |
|||
| MBS858415-01mLAF635 | MyBiosource | 0.1mL(AF635) | 465 EUR |
CIDEB Antibody |
|||
| MBS8583103-01mL | MyBiosource | 0.1mL | 305 EUR |
CIDEB Antibody |
|||
| MBS8583103-01mLAF405L | MyBiosource | 0.1mL(AF405L) | 465 EUR |
CIDEB Antibody |
|||
| MBS8583103-01mLAF405S | MyBiosource | 0.1mL(AF405S) | 465 EUR |
CIDEB Antibody |
|||
| MBS8583103-01mLAF610 | MyBiosource | 0.1mL(AF610) | 465 EUR |
CIDEB Antibody |
|||
| MBS8583103-01mLAF635 | MyBiosource | 0.1mL(AF635) | 465 EUR |
CIDEB Antibody |
|||
| MBS9505793-005mL | MyBiosource | 0.05mL | 285 EUR |
CIDEB Antibody |
|||
| MBS9505793-01mL | MyBiosource | 0.1mL | 385 EUR |
CIDEB Antibody |
|||
| MBS9505793-5x01mL | MyBiosource | 5x0.1mL | 1590 EUR |
CIDEB Antibody |
|||
| MBS9509311-005mL | MyBiosource | 0.05mL | 285 EUR |
CIDEB Antibody |
|||
| MBS9509311-01mL | MyBiosource | 0.1mL | 385 EUR |
CIDEB Antibody |
|||
| MBS9509311-5x01mL | MyBiosource | 5x0.1mL | 1590 EUR |
CIDEB Antibody |
|||
| MBS9605064-01mL | MyBiosource | 0.1mL | 260 EUR |
CIDEB Antibody |
|||
| MBS9605064-02mL | MyBiosource | 0.2mL | 305 EUR |
CIDEB Antibody |
|||
| MBS9605064-5x02mL | MyBiosource | 5x0.2mL | 1220 EUR |
CIDEB Antibody |
|||
| Y058083 | ABM | 100 µl | 145 EUR |
CIDEB Antibody (C-erm) |
|||
| E45G02600G-1 | EnoGene | 100 ul | 395 EUR |
CIDEB Antibody (C-erm) |
|||
| E45G02600G-4 | EnoGene | 50 ul | 295 EUR |
CIDEB Antibody (C-erm) |
|||
| MBS9216910-005mL | MyBiosource | 0.05mL | 210 EUR |
CIDEB Antibody (C-erm) |
|||
| MBS9216910-02mL | MyBiosource | 0.2mL | 430 EUR |
CIDEB Antibody (C-erm) |
|||
| MBS9216910-5x02mL | MyBiosource | 5x0.2mL | 1910 EUR |
CIDEB antibody - middle region |
|||
| MBS3224449-01mL | MyBiosource | 0.1mL | 455 EUR |
CIDEB antibody - middle region |
|||
| MBS3224449-5x01mL | MyBiosource | 5x0.1mL | 1995 EUR |
CIDEB Antibody, HRP conjugated |
|||
| 1-CSB-PA12869B0Rb | Cusabio |
|
|
|
Description: A polyclonal antibody against CIDEB. Recognizes CIDEB from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
|||
CIDEB Antibody, HRP conjugated |
|||
| MBS7049600-005mg | MyBiosource | 0.05mg | 190 EUR |
CIDEB Antibody, HRP conjugated |
|||
| MBS7049600-01mg | MyBiosource | 0.1mg | 270 EUR |
CIDEB Antibody, HRP conjugated |
|||
| MBS7049600-5x01mg | MyBiosource | 5x0.1mg | 1205 EUR |
CIDEB Antibody, FITC conjugated |
|||
| 1-CSB-PA12869C0Rb | Cusabio |
|
|
|
Description: A polyclonal antibody against CIDEB. Recognizes CIDEB from Human. This antibody is FITC conjugated. Tested in the following application: ELISA |
|||
CIDEB Antibody, FITC conjugated |
|||
| MBS7049601-005mg | MyBiosource | 0.05mg | 190 EUR |
CIDEB Antibody, FITC conjugated |
|||
| MBS7049601-01mg | MyBiosource | 0.1mg | 270 EUR |
CIDEB Antibody, FITC conjugated |
|||
| MBS7049601-5x01mg | MyBiosource | 5x0.1mg | 1205 EUR |
OACA10458-50UG - CIDEB Antibody |
|||
| OACA10458-50UG | Aviva Systems Biology | 50ug | 179 EUR |
CIDEB Antibody, Biotin conjugated |
|||
| 1-CSB-PA12869D0Rb | Cusabio |
|
|
|
Description: A polyclonal antibody against CIDEB. Recognizes CIDEB from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA |
|||
CIDEB Antibody, Biotin conjugated |
|||
| MBS7049602-005mg | MyBiosource | 0.05mg | 190 EUR |
CIDEB Antibody, Biotin conjugated |
|||
| MBS7049602-01mg | MyBiosource | 0.1mg | 270 EUR |
CIDEB Antibody, Biotin conjugated |
|||
| MBS7049602-5x01mg | MyBiosource | 5x0.1mg | 1205 EUR |
OACA10458-100UG - CIDEB Antibody |
|||
| OACA10458-100UG | Aviva Systems Biology | 100ug | 319 EUR |
Rabbit Polyclonal CIDEB Antibody |
|||
| TA336317 | Origene Technologies GmbH | 100 µg | Ask for price |
Polyclonal CIDEB Antibody (Internal) |
|||
| APG02602G | Leading Biology | 0.05mg | 580.8 EUR |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human CIDEB (Internal). This antibody is tested and proven to work in the following applications: |
|||
Human CIDEB siRNA |
|||
| 20-abx911865 | Abbexa |
|
|
CIDEB Polyclonal Antibody |
|||
| E-AB-14428-120uL | Elabscience Biotech | 120uL | 240 EUR |
|
Description: Unconjugated |
|||
CIDEB Polyclonal Antibody |
|||
| E-AB-14428-200uL | Elabscience Biotech | 200uL | 399 EUR |
|
Description: Unconjugated |
|||
CIDEB Polyclonal Antibody |
|||
| E-AB-14428-20uL | Elabscience Biotech | 20uL | 73 EUR |
|
Description: Unconjugated |
|||
CIDEB Polyclonal Antibody |
|||
| E-AB-14428-60uL | Elabscience Biotech | 60uL | 143 EUR |
|
Description: Unconjugated |
|||
CIDEB Polyclonal Antibody |
|||
| E-AB-10667-120uL | Elabscience Biotech | 120uL | 240 EUR |
|
Description: Unconjugated |
|||
CIDEB Polyclonal Antibody |
|||
| E-AB-10667-200uL | Elabscience Biotech | 200uL | 399 EUR |
|
Description: Unconjugated |
|||
CIDEB Polyclonal Antibody |
|||
| E-AB-10667-20uL | Elabscience Biotech | 20uL | 73 EUR |
|
Description: Unconjugated |
|||
CIDEB Polyclonal Antibody |
|||
| E-AB-10667-60uL | Elabscience Biotech | 60uL | 143 EUR |
|
Description: Unconjugated |
|||
CIDEB polyclonal antibody |
|||
| BS61564 | Bioworld Biotech | 50ul | 275 EUR |
|
Description: Rabbit IgG, 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2 |
|||
CIDEB polyclonal antibody |
|||
| BS77115 | Bioworld Biotech | 50ul | 358 EUR |
|
Description: 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2 |
|||
CIDEB Polyclonal Antibody |
|||
| E-AB-91710-120uL | Elabscience Biotech | 120uL | 320 EUR |
|
Description: Unconjugated |
|||
CIDEB Polyclonal Antibody |
|||
| E-AB-91710-200uL | Elabscience Biotech | 200uL | 530 EUR |
|
Description: Unconjugated |
|||
CIDEB Polyclonal Antibody |
|||
| E-AB-91710-60uL | Elabscience Biotech | 60uL | 200 EUR |
|
Description: Unconjugated |
|||
CIDEB Polyclonal Antibody |
|||
| E-AB-91710-each | Elabscience Biotech | each | Ask for price |
|
Description: Unconjugated |
|||
CIDEB Polyclonal Antibody |
|||
| E917141 | EnoGene | 100ul | 225 EUR |
|
Description: Available in various conjugation types. |
|||
CIDEB Polyclonal Antibody |
|||
| MBS2518520-002mL | MyBiosource | 0.02mL | 135 EUR |
CIDEB Polyclonal Antibody |
|||
| MBS2518520-006mL | MyBiosource | 0.06mL | 190 EUR |
CIDEB Polyclonal Antibody |
|||
| MBS2518520-012mL | MyBiosource | 0.12mL | 265 EUR |
CIDEB Polyclonal Antibody |
|||
| MBS2518520-02mL | MyBiosource | 0.2mL | 415 EUR |
CIDEB Polyclonal Antibody |
|||
| MBS2518520-5x02mL | MyBiosource | 5x0.2mL | 1835 EUR |
CIDEB Polyclonal Antibody |
|||
| MBS2519060-002mL | MyBiosource | 0.02mL | 135 EUR |
CIDEB Polyclonal Antibody |
|||
| MBS2519060-006mL | MyBiosource | 0.06mL | 190 EUR |
CIDEB Polyclonal Antibody |
|||
| MBS2519060-012mL | MyBiosource | 0.12mL | 265 EUR |
CIDEB Polyclonal Antibody |
|||
| MBS2519060-02mL | MyBiosource | 0.2mL | 415 EUR |
CIDEB Polyclonal Antibody |
|||
| MBS2519060-5x02mL | MyBiosource | 5x0.2mL | 1835 EUR |
CIDEB Polyclonal Antibody |
|||
| MBS9141051-002mL | MyBiosource | 0.02mL | 200 EUR |
CIDEB Polyclonal Antibody |
|||
| MBS9141051-005mL | MyBiosource | 0.05mL | 255 EUR |
CIDEB Polyclonal Antibody |
|||
| MBS9141051-01mL | MyBiosource | 0.1mL | 345 EUR |
CIDEB Polyclonal Antibody |
|||
| MBS9141051-02mL | MyBiosource | 0.2mL | 545 EUR |
CIDEB Polyclonal Antibody |
|||
| MBS9141051-5x02mL | MyBiosource | 5x0.2mL | 2265 EUR |
CIDEB Polyclonal Antibody |
|||
| MBS8571768-01mL | MyBiosource | 0.1mL | 305 EUR |
CIDEB Polyclonal Antibody |
|||
| MBS8571768-01mLAF405L | MyBiosource | 0.1mL(AF405L) | 565 EUR |
CIDEB Polyclonal Antibody |
|||
| MBS8571768-01mLAF405S | MyBiosource | 0.1mL(AF405S) | 565 EUR |
CIDEB Polyclonal Antibody |
|||
| MBS8571768-01mLAF610 | MyBiosource | 0.1mL(AF610) | 565 EUR |
CIDEB Polyclonal Antibody |
|||
| MBS8571768-01mLAF635 | MyBiosource | 0.1mL(AF635) | 565 EUR |
Corticotropin-Releasing Issue: An Historical Peptide Household Associated to the Secretin Peptide Superfamily
Corticotropin-releasing issue (CRF) is the hypothalamic releasing peptide that regulates the hypothalamic-pituitary-adrenal/inter-renal (HPA/I) axis in vertebrates. During the last 25 years, there was appreciable dialogue on its paralogs genes, urotensin-I/urocortin-1, and urocortins-2 and-Three and their subsequent position within the vertebrate stress response.
Phylogenetically, the CRF household of peptides additionally belong to the various assemblage of Secretin- and Calcitonin-based peptides as evidenced by comparative-based research of each their ligand and G-protein-coupled receptor (GPCR) constructions. Regardless of this, the frequent origin of this massive assemblage of peptides has not been ascertained.
An uncommon peptide, teneurin-C-terminal related peptide (TCAP), reported in 2004, contains the distal extracellular tip of the teneurin transmembrane proteins. Additional research indicated that this teneurin area binds to the latrophilin household of GPCRs. Initially regarded as a member of the Secretin GPCR household, proof signifies that the latrophilins are a member of the Adhesion household of GPCRs and are associated to the frequent ancestor of each Adhesion and Secretin GPCR households.
On this examine, we posit that TCAP could also be a distantly associated ancestor of the CRF-Calcitonin-Secretin peptide household and advanced close to the bottom of metazoan phylogeny.
Self-Immobilized Putrescine Oxidase Biocatalyst System Engineered with a Metallic Binding Peptide
Flavin oxidases are priceless biocatalysts for the oxidative synthesis of a big selection of compounds, whereas on the similar time decreasing oxygen to hydrogen peroxide. In comparison with different redox enzymes, their capability to make use of molecular oxygen as an electron acceptor provides a comparatively easy system which doesn’t require a dissociable coenzyme. As such, they’re enticing targets for adaptation as price efficient biosensor parts. Their practical immobilization on surfaces provides distinctive alternatives to broaden their utilization for a variety of purposes. Genetically engineered peptides have been demonstrated as enablers of the practical meeting of biomolecules at stable supplies interfaces.
As soon as recognized as having a excessive affinity for the fabric of curiosity, these peptides can present a single step bio-assembly course of with orientation management, a essential parameter for practical immobilization of the enzymes. On this examine, for the primary time, we explored bio-assembly of a putrescine oxidase enzyme utilizing a gold binding peptide tag.
The enzyme was genetically engineered to include a gold binding peptide with an expectation of efficient show of the peptide tag to work together with the gold floor. On this work, the practical exercise and expression have been investigated, together with the selectivity of the binding of the peptide tagged enzyme. The fusion enzyme was characterised utilizing a number of strategies together with protein electrophoresis, enzyme exercise, microscopic and spectroscopic strategies to confirm practical expression of the tagged protein with close to native exercise.
Binding research utilizing quartz crystal microbalance (QCM), nanoparticle binding research, and atomic power microscopy research have been used to deal with the selectivity of the binding by means of the peptide tag. Floor binding AFM research present that the binding was selective for gold. Quartz crystal microbalance research present a robust enhance within the affinity of the peptide tagged protein over the native enzyme, whereas exercise assays of protein sure to nanoparticles present proof that the enzyme retained catalytic exercise when immobilized.
Along with displaying selectivity, AFM photos present important variations within the peak of the molecules when immobilized by means of the peptide tag in comparison with immobilization of the native enzyme, indicating variations in orientation of the sure enzyme when connected through the affinity tag. Controlling orientation of floor immobilized enzymes would additional enhance their enzymatic exercise and impression numerous purposes together with oxidative biocatalysis, biosensors, biochips, and biofuel manufacturing.
BICD2 Peptide |
|||
| 4677P | ProSci | 0.05 mg | 197.7 EUR |
|
Description: (IN) BICD2 peptide |
|||
BICD2 Peptide |
|||
| MBS152448-005mg | MyBiosource | 0.05mg | 175 EUR |
BICD2 Peptide |
|||
| MBS152448-5x005mg | MyBiosource | 5x0.05mg | 770 EUR |
BICD2 Peptide |
|||
| MBS152730-005mg | MyBiosource | 0.05mg | 175 EUR |
BICD2 Peptide |
|||
| MBS152730-5x005mg | MyBiosource | 5x0.05mg | 770 EUR |
Mast Cell-Degranulating Peptide (MCD Peptide) / Peptide 401 |
|||
| 004-04 | PHOENIX PEPTIDE | 100 μg | 140.4 EUR |
BICD2 Peptide - middle region |
|||
| MBS3244293-01mg | MyBiosource | 0.1mg | 180 EUR |
BICD2 Peptide - middle region |
|||
| MBS3244293-5x01mg | MyBiosource | 5x0.1mg | 730 EUR |
Peptide T |
|||
| 057-01 | PHOENIX PEPTIDE | 5 mg | 140.4 EUR |
FGL Peptide |
|||
| 073-36 | PHOENIX PEPTIDE | 100 μg | 214.92 EUR |
APK peptide |
|||
| 076-81 | PHOENIX PEPTIDE | 200 μg | 199.8 EUR |
NEF peptide |
|||
| 076-83 | PHOENIX PEPTIDE | 500 μg | 140.4 EUR |
SHA peptide |
|||
| 076-84 | PHOENIX PEPTIDE | 500 μg | 177.12 EUR |
YSY peptide |
|||
| 076-86 | PHOENIX PEPTIDE | 100 μg | 230.04 EUR |
Peptide E / 3200-Dalton Adrenal Enkephalin-Containing Peptide (Bovine) |
|||
| 024-57 | PHOENIX PEPTIDE | 200 μg | 86.4 EUR |
PSTAIR Peptide |
|||
| 070-61 | PHOENIX PEPTIDE | 500 μg | 129.6 EUR |
PGMtide Peptide |
|||
| 040-69 | PHOENIX PEPTIDE | 100 μg | 316.44 EUR |
Adjuvant Peptide |
|||
| 070-05 | PHOENIX PEPTIDE | 500 μg | 36.72 EUR |
Peptide-epsilon |
|||
| 058-22 | PHOENIX PEPTIDE | 500 μg | 114.48 EUR |
Delicious Peptide |
|||
| 070-21 | PHOENIX PEPTIDE | 5 mg | 160.92 EUR |
proSex peptide (20-55) |
|||
| 040-30 | PHOENIX PEPTIDE | 100 μg | 355.32 EUR |
proSex peptide (28-55) |
|||
| 040-31 | PHOENIX PEPTIDE | 100 μg | 282.96 EUR |
proSex peptide (40-55) |
|||
| 040-32 | PHOENIX PEPTIDE | 100 μg | 214.92 EUR |
Bombinin-Like Peptide 1 amide / prepro-Bombinin-Like Peptide (44-70) amide / prepro-Bombinin-Like Peptide (107-133) amide |
|||
| 007-60 | PHOENIX PEPTIDE | 100 μg | 214.92 EUR |
Peptide F-9 |
|||
| 038-06 | PHOENIX PEPTIDE | 200 μg | 58.32 EUR |
Sturgeon Peptide (137-158) |
|||
| 021-94 | PHOENIX PEPTIDE | 100 μg | 177.12 EUR |
NGR Peptide 1 |
|||
| 025-74 | PHOENIX PEPTIDE | 200 μg | 184.68 EUR |
Peptide Lv (Rat) |
|||
| 008-73 | PHOENIX PEPTIDE | 100 μg | 469.8 EUR |
Anorexigenic Peptide |
|||
| 070-10 | PHOENIX PEPTIDE | 5 mg | 86.4 EUR |
GnRH Associated Peptide (GAP) (1-13) / GnRH Precursor Peptide (14-26) (Human) |
|||
| 029-03 | PHOENIX PEPTIDE | 500 μg | 114.48 EUR |
GnRH Associated Peptide (GAP) (1-24) / GnRH Precursor Peptide (14-37) (Human) |
|||
| 029-04 | PHOENIX PEPTIDE | 100 μg | 114.48 EUR |
GnRH Associated Peptide (GAP) (1-53) / GnRH Precursor Peptide (14-66) (Human) |
|||
| 029-05 | PHOENIX PEPTIDE | 20 μg | 267.84 EUR |
GnRH Associated Peptide (GAP) (25-53) / GnRH Precursor Peptide (38-66) (Human) |
|||
| 029-06 | PHOENIX PEPTIDE | 100 μg | 114.48 EUR |
Bid BH3 peptide |
|||
| 025-87 | PHOENIX PEPTIDE | 1 mg | 170.64 EUR |
AF-16 Peptide |
|||
| 033-44 | PHOENIX PEPTIDE | 200 μg | 214.92 EUR |
Peptide Lv (Human) |
|||
| 008-71 | PHOENIX PEPTIDE | 100 μg | 405 EUR |
Peptide Lv (Mouse) |
|||
| 008-72 | PHOENIX PEPTIDE | 100 μg | 469.8 EUR |
GnRH Associated Peptide (GAP) (1-13) / Gn-RH Precursor Peptide (14-26) (Rat) |
|||
| 029-08 | PHOENIX PEPTIDE | 200 μg | 64.8 EUR |
ExE peptide M3mP6 |
|||
| 064-33 | PHOENIX PEPTIDE | 200 μg | 244.08 EUR |
Peptide B (Bovine) |
|||
| 024-56 | PHOENIX PEPTIDE | 200 μg | 81 EUR |
Peptide F (Bovine) |
|||
| 024-58 | PHOENIX PEPTIDE | 200 μg | 114.48 EUR |
PLP Peptide (103-116) (Bovine) |
|||
| 070-14 | PHOENIX PEPTIDE | 5 mg | 140.4 EUR |
FMRF-Like Peptide |
|||
| 047-32 | PHOENIX PEPTIDE | 1 mg | 27 EUR |
Joining Peptide (Rat) |
|||
| 047-91 | PHOENIX PEPTIDE | 200 μg | 160.92 EUR |
Growth Hormone-Releasing Peptide-Related Peptide-1 (fGRP-RP-1) (Frog) |
|||
| 048-80 | PHOENIX PEPTIDE | 500 μg | 177.12 EUR |
Growth Hormone-Releasing Peptide-Related Peptide-2 (fGRP-RP-2) (Frog) |
|||
| 048-81 | PHOENIX PEPTIDE | 200 μg | 214.92 EUR |
Growth Hormone-Releasing Peptide-Related Peptide-3 (fGRP-RP-3) (Frog) |
|||
| 048-82 | PHOENIX PEPTIDE | 200 μg | 214.92 EUR |
Peptide T (4-8) |
|||
| 057-04 | PHOENIX PEPTIDE | 500 μg | 64.8 EUR |
Peptide T (5-8) |
|||
| 057-05 | PHOENIX PEPTIDE | 500 μg | 64.8 EUR |
Vasonatrin Peptide (VNP) |
|||
| 005-47 | PHOENIX PEPTIDE | 200 μg | 214.92 EUR |
Opioid Peptide Library |
|||
| L-002 | PHOENIX PEPTIDE | 58 peptides | 2691.36 EUR |
Peptide Histidine Isoleucine 27 (PHI-27) / Porcine Intestinal Peptide (Porcine) |
|||
| 064-01 | PHOENIX PEPTIDE | 200 μg | 108 EUR |
PGMtide Control Peptide |
|||
| 040-70 | PHOENIX PEPTIDE | 100 μg | 316.44 EUR |
Growth Blocking Peptide |
|||
| 046-92 | PHOENIX PEPTIDE | 100 μg | 255.96 EUR |
Neuron Specific Peptide |
|||
| 047-55 | PHOENIX PEPTIDE | 200 μg | 140.4 EUR |
Heparin Binding Peptide |
|||
| 025-47 | PHOENIX PEPTIDE | 500 μg | 102.6 EUR |
Gastrin Related Peptide |
|||
| 027-09 | PHOENIX PEPTIDE | 5 mg | 73.44 EUR |
Obesity Peptide Library |
|||
| L-003 | PHOENIX PEPTIDE | 160 peptides | 7267.32 EUR |
[D-Ala1]-Peptide T |
|||
| 057-02 | PHOENIX PEPTIDE | 5 mg | 282.96 EUR |
Peptide YY (PYY) (Human) |
|||
| 059-01 | PHOENIX PEPTIDE | 200 μg | 119.88 EUR |
Eledoisin Related Peptide |
|||
| 046-04 | PHOENIX PEPTIDE | 5 mg | 58.32 EUR |
proSex peptide (28-55) - EIA Kit |
|||
| EK-040-31 | PHOENIX PEPTIDE | 96 wells | 603.72 EUR |
Peptide F 1 (Lobster) |
|||
| 047-62 | PHOENIX PEPTIDE | 500 μg | 73.44 EUR |
Phosphate Acceptor Peptide |
|||
| 058-24 | PHOENIX PEPTIDE | 500 μg | 73.44 EUR |
Morphine Tolerance Peptide |
|||
| 050-13 | PHOENIX PEPTIDE | 1 mg | 102.6 EUR |
Peptide Histidine Methionine 27 (PHM-27) / Peptide Histidine Isoleucine (PHI) (Human) |
|||
| 064-07 | PHOENIX PEPTIDE | 200 μg | 114.48 EUR |
Peptide I / pro-Histine-Rich Basic Peptide (HRBP) (1-26) (Aplysia brasiliana) |
|||
| 047-39 | PHOENIX PEPTIDE | 200 μg | 444.96 EUR |
Peptide II / pro-Histine-Rich Basic Peptide (HRBP) (29-40) (Aplysia brasiliana) |
|||
| 047-40 | PHOENIX PEPTIDE | 500 μg | 214.92 EUR |
Peptide I / pro-Histine-Rich Basic Peptide (HRBP) (1-26) (Aplysia californica) |
|||
| 047-42 | PHOENIX PEPTIDE | 200 μg | 444.96 EUR |
Peptide II / pro-Histine-Rich Basic Peptide (HRBP) (29-40) (Aplysia californica) |
|||
| 047-43 | PHOENIX PEPTIDE | 500 μg | 214.92 EUR |
FGL Peptide - Cy3 Labeled |
|||
| FC3-073-36 | PHOENIX PEPTIDE | 1 nmol | 672.84 EUR |
FGL Peptide - Cy5 Labeled |
|||
| FC5-073-36 | PHOENIX PEPTIDE | 1 nmol | 756 EUR |
FGL Peptide - FAM Labeled |
|||
| FG-073-36A | PHOENIX PEPTIDE | 1 nmol | 405 EUR |
Pedal Peptide (Pep) (Aplysia) |
|||
| 047-61 | PHOENIX PEPTIDE | 500 μg | 177.12 EUR |
ExE peptide M3mP6 mutant |
|||
| 064-35 | PHOENIX PEPTIDE | 200ug | 234.36 EUR |
ExE peptide M3mP6 mutant |
|||
| 064-37 | PHOENIX PEPTIDE | 200ug | 234.36 EUR |
AF-16 Peptide - Antibody |
|||
| H-033-44 | PHOENIX PEPTIDE | 100 μl | 336.96 EUR |
FGL Peptide - FITC Labeled |
|||
| FG-073-36B | PHOENIX PEPTIDE | 1 nmol | 405 EUR |
Schizophrenia Related Peptide |
|||
| 047-79 | PHOENIX PEPTIDE | 5 mg | 44.28 EUR |
Insulin B (22-25) Peptide |
|||
| 035-08 | PHOENIX PEPTIDE | 5 mg | 86.4 EUR |
Eosinophilotactic Peptide (AGSE) |
|||
| 070-28 | PHOENIX PEPTIDE | 5 mg | 27 EUR |
Eosinophilotactic Peptide (VGSE) |
|||
| 070-29 | PHOENIX PEPTIDE | 5 mg | 27 EUR |
Cell Penetrating ARF Peptide (26-44) |
|||
| 068-56 | PHOENIX PEPTIDE | 500 μg | 640.44 EUR |
Peptide Histidine Isoleucine 27 (PHI-27) / Porcine Intestinal Peptide (Porcine) - RIA Kit |
|||
| RK-064-01 | PHOENIX PEPTIDE | 125 tubes | 932.04 EUR |
FGL Peptide - Biotin Labeled |
|||
| B-073-36 | PHOENIX PEPTIDE | 20 μg | 405 EUR |
Peptide F (Bovine) - Antibody |
|||
| H-024-58 | PHOENIX PEPTIDE | 50 μl | 238.68 EUR |
Brain Peptide (Bees) Library |
|||
| L-007 | PHOENIX PEPTIDE | 51 peptides | 6456.24 EUR |
AAP73770-100UG - BICD2 Peptide - middle region |
|||
| AAP73770-100UG | Aviva Systems Biology | 100ug | 99 EUR |
BICD1 Antibody |
|||
| 24710 | SAB | 100ul | 479 EUR |
BICD1 Antibody |
|||
| 24710-100ul | SAB | 100ul | 468 EUR |
BICD1 Antibody |
|||
| 4663-002mg | ProSci | 0.02 mg | 206.18 EUR |
|
Description: BICD1 Antibody: BICD1 was initially identified as the human homolog to Drosophila Bicaudal-D protein that forms part of the cytoskeleton and mediates the correct sorting of mRNAs for oocyte- and axis-determining factors during oogenesis. BICD1 can bind to dynein-dynactin and co-localizes with Rab6A on the trans-Golgi network and cytoplasmic vesicles, suggesting BICD1 regulates COPI-independent Golgi-ER transport. BICD1 will also interact with Rab6B, a Rab6 isoform that is expressed primarily in brain. Live cell imaging showed bi-directional movement of Rab6B structures in SK-N-SH neurites, indicating that BICD1 is involved in the Rab6B regulation of retrograde cargo transport in neuronal cells. |
|||
BICD1 Antibody |
|||
| 4663-01mg | ProSci | 0.1 mg | 523.7 EUR |
|
Description: BICD1 Antibody: BICD1 was initially identified as the human homolog to Drosophila Bicaudal-D protein that forms part of the cytoskeleton and mediates the correct sorting of mRNAs for oocyte- and axis-determining factors during oogenesis. BICD1 can bind to dynein-dynactin and co-localizes with Rab6A on the trans-Golgi network and cytoplasmic vesicles, suggesting BICD1 regulates COPI-independent Golgi-ER transport. BICD1 will also interact with Rab6B, a Rab6 isoform that is expressed primarily in brain. Live cell imaging showed bi-directional movement of Rab6B structures in SK-N-SH neurites, indicating that BICD1 is involved in the Rab6B regulation of retrograde cargo transport in neuronal cells. |
|||
BICD1 Antibody |
|||
| 43846 | SAB | 100ul | 319 EUR |
BICD1 Antibody |
|||
| 43846-100ul | SAB | 100ul | 302.4 EUR |
BICD1 Antibody |
|||
| E043846 | EnoGene | 100μg/100μl | 255 EUR |
|
Description: Available in various conjugation types. |
|||
BICD1 Antibody |
|||
| E40P11761 | EnoGene | 50ul | 395 EUR |
|
Description: Available in various conjugation types. |
|||
BICD1 Antibody |
|||
| MBS150672-01mg | MyBiosource | 0.1mg | 445 EUR |
BICD1 Antibody |
|||
| MBS150672-5x01mg | MyBiosource | 5x0.1mg | 1965 EUR |
BICD1 Antibody |
|||
| MBS9410273-01mL | MyBiosource | 0.1mL | 495 EUR |
BICD1 Antibody |
|||
| MBS9410273-5x01mL | MyBiosource | 5x0.1mL | 2075 EUR |
BICD1 Antibody |
|||
| MBS9417265-01mL | MyBiosource | 0.1mL | 305 EUR |
BICD1 Antibody |
|||
| MBS9417265-5x01mL | MyBiosource | 5x0.1mL | 1230 EUR |
Gastrointestinal Peptide Library |
|||
| L-006 | PHOENIX PEPTIDE | 200 peptides | 7267.32 EUR |
Peptide R / CXCR4 Antagonist |
|||
| 030-25 | PHOENIX PEPTIDE | 200 μg | 203.04 EUR |
PGMtide Peptide - Cy3 Labeled |
|||
| FC3-040-69 | PHOENIX PEPTIDE | 1 nmol | 925.56 EUR |
PGMtide Peptide - FAM Labeled |
|||
| FG-040-69A | PHOENIX PEPTIDE | 5 nmol | 537.84 EUR |
[D-Arg14, D-Arg15]-MGF Peptide amide / C-terminal peptide of IGF-1 Ec amide |
|||
| 033-34 | PHOENIX PEPTIDE | 100 μg | 177.12 EUR |
Peptide Histidine Methionine 27 (PHM-27) / Peptide Histidine Isoleucine (PHI) (Human) - Antibody |
|||
| H-064-07 | PHOENIX PEPTIDE | 50 μl | 238.68 EUR |
[D-Ala1]-Peptide T amide |
|||
| 057-03 | PHOENIX PEPTIDE | 500 μg | 140.4 EUR |
Peptide F (Bovine) - RIA Kit |
|||
| RK-024-58 | PHOENIX PEPTIDE | 125 tubes | 932.04 EUR |
Calmodulin Binding Peptide 1 |
|||
| 070-17 | PHOENIX PEPTIDE | 20 μg | 214.92 EUR |
Catch-Relaxing Peptide (CARP) |
|||
| 047-20 | PHOENIX PEPTIDE | 1 mg | 199.8 EUR |
FGL Peptide - Rhodamine Labeled |
|||
| FR-073-36 | PHOENIX PEPTIDE | 1 nmol | 537.84 EUR |
Peptide-Depleted Plasma (Rat) |
|||
| MB-099-02 | PHOENIX PEPTIDE | 2 ml | 119.88 EUR |
Peptide Histidine Methionine 27 (PHM-27) / Peptide Histidine Isoleucine (PHI) (Human) - RIA Kit |
|||
| RK-064-07 | PHOENIX PEPTIDE | 125 tubes | 932.04 EUR |
Glycogenolysis-Inhibiting Peptide |
|||
| 023-63 | PHOENIX PEPTIDE | 500 μg | 177.12 EUR |
Anti-Inflammatory Peptide 1 |
|||
| 004-01 | PHOENIX PEPTIDE | 200 μg | 27 EUR |
Anti-Inflammatory Peptide 2 |
|||
| 004-02 | PHOENIX PEPTIDE | 200 μg | 27 EUR |
Anti-Inflammatory Peptide 3 |
|||
| 004-03 | PHOENIX PEPTIDE | 200 μg | 27 EUR |
Urokinase-Derived Peptide A6 |
|||
| 025-12 | PHOENIX PEPTIDE | 500 μg | 129.6 EUR |
PGMtide Peptide - Biotin Labeled |
|||
| B-040-69 | PHOENIX PEPTIDE | 20 μg | 537.84 EUR |
Peptide 34 / GPR-54 Agonist |
|||
| 048-94 | PHOENIX PEPTIDE | 200 μg | 114.48 EUR |
FGL Peptide - I-125 Labeled |
|||
| T-073-36 | PHOENIX PEPTIDE | 10 μCi | 1145.88 EUR |
Peptide-Depleted Plasma (Human) |
|||
| MB-099-01 | PHOENIX PEPTIDE | 2 ml | 119.88 EUR |
Peptide Histidine Methionine 27 (PHM-27) / Peptide Histidine Isoleucine (PHI) (Human) - FAM Labeled |
|||
| FG-064-07A | PHOENIX PEPTIDE | 1 nmol | 336.96 EUR |
Peptide Histidine Isoleucine 27 (PHI-27) / Porcine Intestinal Peptide (Porcine) - I-125 Labeled |
|||
| T-064-01 | PHOENIX PEPTIDE | 10 μCi | 1145.88 EUR |
F3 Peptide / HMGN2 Fragment 3 |
|||
| 004-12 | PHOENIX PEPTIDE | 100 μg | 214.92 EUR |
Myosin Kinase Inhibiting Peptide |
|||
| 058-20 | PHOENIX PEPTIDE | 500 μg | 50.76 EUR |
Antimicrobial Trp-rich peptide |
|||
| 004-05 | PHOENIX PEPTIDE | 100 μg | 140.4 EUR |
Fibronectin CS1 Peptide (EILDVPST) |
|||
| 025-20 | PHOENIX PEPTIDE | 500 μg | 86.4 EUR |
Peptide YY (PYY) (3-36) (Human) |
|||
| 059-02 | PHOENIX PEPTIDE | 200 μg | 102.6 EUR |
Peptide YY (PYY) (Human) - Antibody |
|||
| H-059-01 | PHOENIX PEPTIDE | 100 μl | 469.8 EUR |
PGMtide Peptide - Rhodamine Labeled |
|||
| FR-040-69 | PHOENIX PEPTIDE | 5 nmol | 604.8 EUR |
Anti-Angiogenic Peptide Library |
|||
| L-008A | PHOENIX PEPTIDE | 88 peptides | 6067.44 EUR |
Peptide Histidine Isoleucine 27 (PHI-27) / Porcine Intestinal Peptide (Porcine) - Purified IgG Antibody |
|||
| G-064-01 | PHOENIX PEPTIDE | 400 μg | 438.48 EUR |
Peptide A / p60v-src (137-157) |
|||
| 058-21 | PHOENIX PEPTIDE | 500 μg | 135 EUR |
pro-Opionmelanocortin / J Peptide |
|||
| 022-22 | PHOENIX PEPTIDE | 200 μg | 177.12 EUR |
Cancer-Targeting Peptide Library |
|||
| L-015 | PHOENIX PEPTIDE | 289 peptides | 7253.28 EUR |
C28 optimized peptide 6 (Human) |
|||
| 073-82 | PHOENIX PEPTIDE | 100 μg | 235.44 EUR |
Peptide YY (PYY) (Human) - EIA Kit |
|||
| EK-059-01 | PHOENIX PEPTIDE | 96 wells | 617.76 EUR |
Peptide YY (PYY) (Human) - RIA Kit |
|||
| RK-059-01 | PHOENIX PEPTIDE | 125 tubes | 814.32 EUR |
Kemptide / Phosphate Acceptor Peptide |
|||
| 058-16 | PHOENIX PEPTIDE | 500 μg | 36.72 EUR |
Bioactive Secretory Peptide Library |
|||
| L-009 | PHOENIX PEPTIDE | 1016 peptides | 31350.24 EUR |
PACAP-Related Peptide (PRP) (Rat) |
|||
| 052-11 | PHOENIX PEPTIDE | 200 μg | 86.4 EUR |
Galanin-Like Peptide (GALP) (Rat) |
|||
| 026-52 | PHOENIX PEPTIDE | 100 μg | 282.96 EUR |
Peptide Histidine Methionine 27 (PHM-27) / Peptide Histidine Isoleucine (PHI) (Human) - I-125 Labeled |
|||
| T-064-07 | PHOENIX PEPTIDE | 10 μCi | 1145.88 EUR |
Virus Replication Inhibiting Peptide |
|||
| 070-85 | PHOENIX PEPTIDE | 5 mg | 160.92 EUR |
Crustacean Cardioactive Peptide (CCAP) |
|||
| 047-24 | PHOENIX PEPTIDE | 500 μg | 86.4 EUR |
Pri Peptide from sORF pri RNA |
|||
| 069-77 | PHOENIX PEPTIDE | 200 μg | 160.92 EUR |
Alzheimer Fingerprint Peptide Library |
|||
| L-011 | PHOENIX PEPTIDE | 85 peptides | 6529.68 EUR |
PACAP-Related Peptide (PRP) (Human) |
|||
| 052-10 | PHOENIX PEPTIDE | 200 μg | 86.4 EUR |
Scrambled Control for Pri Peptide |
|||
| 069-78 | PHOENIX PEPTIDE | 200 μg | 160.92 EUR |
FMRF-Like Peptide (Helix aspersa) |
|||
| 047-31 | PHOENIX PEPTIDE | 1 mg | 27 EUR |
Annexin A1 Binding Peptide, IF7CRR |
|||
| 025-72 | PHOENIX PEPTIDE | 200 μg | 184.68 EUR |
Galanin-Like Peptide (GALP) (Human) |
|||
| 026-51 | PHOENIX PEPTIDE | 100 μg | 230.04 EUR |
Gastrin Releasing Peptide (GRP) (Rat) |
|||
| 027-32 | PHOENIX PEPTIDE | 100 μg | 160.92 EUR |
u PAR (84-95) Scrambled Peptide |
|||
| 072-47 | PHOENIX PEPTIDE | 200 μg | 177.12 EUR |
Kinetensin / Neurotensin Related Peptide |
|||
| 048-01 | PHOENIX PEPTIDE | 500 μg | 58.32 EUR |
Small Cardioactive Peptide A (SCPA) |
|||
| 047-76 | PHOENIX PEPTIDE | 1 mg | 64.8 EUR |
Gastrin Releasing Peptide (GRP) (Frog) |
|||
| 027-33 | PHOENIX PEPTIDE | 100 μg | 160.92 EUR |
Epidermal Growth Factor Receptor Peptide (985-996) |
|||
| 030-05 | PHOENIX PEPTIDE | 500 μg | 102.6 EUR |
Peptide Histidine Methionine 27 (PHM-27) / Peptide Histidine Isoleucine (PHI) (Human) - Purified IgG Antibody |
|||
| G-064-07 | PHOENIX PEPTIDE | 400 μg | 438.48 EUR |
BICD2 Antibody (C-term) Blocking Peptide |
|||
| MBS9227231-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Galanin-Like Peptide (GALP) (Porcine) |
|||
| 026-50 | PHOENIX PEPTIDE | 100 μg | 230.04 EUR |
Gastrin Releasing Peptide (GRP) (Human) |
|||
| 027-07 | PHOENIX PEPTIDE | 200 μg | 119.88 EUR |
Gastrin Releasing Peptide (GRP) (Mouse) |
|||
| 027-40 | PHOENIX PEPTIDE | 100 μg | 160.92 EUR |
PGMtide Control Peptide - Cy3 Labeled |
|||
| FC3-040-70 | PHOENIX PEPTIDE | 1 nmol | 925.56 EUR |
PGMtide Control Peptide - FAM Labeled |
|||
| FG-040-70A | PHOENIX PEPTIDE | 5 nmol | 537.84 EUR |
Growth Blocking Peptide - FAM Labeled |
|||
| FG-046-92A | PHOENIX PEPTIDE | 1 nmol | 336.96 EUR |
Chop-Suey / Variety Peptide Library |
|||
| L-001 | PHOENIX PEPTIDE | 238 peptides | 7400.16 EUR |
T3 Peptide / Tumstatin (69-88) (Human) |
|||
| 016-50 | PHOENIX PEPTIDE | 100 μg | 255.96 EUR |
T7 Peptide / Tumstatin (74-98) (Human) |
|||
| 016-51 | PHOENIX PEPTIDE | 100 μg | 255.96 EUR |
Peptide YY (PYY) (1-36)-Gly (Human) |
|||
| 059-07 | PHOENIX PEPTIDE | 100 μg | 295.92 EUR |
Peptide YY (PYY) (3-36)-Gly (Human) |
|||
| 059-08 | PHOENIX PEPTIDE | 100 μg | 282.96 EUR |
Peptide YY (PYY) (2-36)-Gly (Human) |
|||
| 059-11 | PHOENIX PEPTIDE | 100 μg | 267.84 EUR |
Peptide YY (PYY) (4-36)-Gly (Human) |
|||
| 059-12 | PHOENIX PEPTIDE | 100 μg | 267.84 EUR |
Hypocholesterolemic Peptide / IIAEK (Bovine) |
|||
| 028-37 | PHOENIX PEPTIDE | 500 μg | 177.12 EUR |
Fractalkine Chemokine Domain peptide (41-52) (Human) |
|||
| 026-82 | PHOENIX PEPTIDE | 200 μg | 160.92 EUR |
Fractalkine Chemokine Domain peptide (53-60) (Human) |
|||
| 026-83 | PHOENIX PEPTIDE | 200 μg | 135 EUR |
Fractalkine Chemokine Domain peptide (60-71) (Human) |
|||
| 026-84 | PHOENIX PEPTIDE | 200 μg | 160.92 EUR |
FMRF-Like Peptide ( Lymnae stagnalis) |
|||
| 047-30 | PHOENIX PEPTIDE | 5 mg | 129.6 EUR |
Peptide F (Bovine) - I-125 Labeled |
|||
| T-024-58 | PHOENIX PEPTIDE | 10 μCi | 1145.88 EUR |
Delta-Sleep-Inducing Peptide (DSIP) |
|||
| 070-22 | PHOENIX PEPTIDE | 500 μg | 27 EUR |
[Thr5]-Speract / Sperm Activating Peptide |
|||
| 070-71 | PHOENIX PEPTIDE | 1 mg | 114.48 EUR |
Kappa-Receptor, C-terminal peptide |
|||
| 002-98 | PHOENIX PEPTIDE | 100 μg | 469.8 EUR |
Angiotensin II - constrained peptide 1 |
|||
| 004-09 | PHOENIX PEPTIDE | 500 μg | 165.24 EUR |
Stresscopin Related Peptide (SRP) (Human) |
|||
| 019-27 | PHOENIX PEPTIDE | 100 μg | 214.92 EUR |
Gastrin Releasing Peptide (GRP) (Porcine) |
|||
| 027-13 | PHOENIX PEPTIDE | 200 μg | 114.48 EUR |
VEGFR binding peptide KH / QKRKRKKSRKKH |
|||
| 007-58 | PHOENIX PEPTIDE | 100 μg | 158.76 EUR |
[D-Ala1]-Peptide T - Biotin Labeled |
|||
| B-057-02 | PHOENIX PEPTIDE | 100 μg | 316.44 EUR |